Related Stories

Physicians Key to Improving Texas’ COVID-19 Vaccine Rates - 05/06/2021

Recent drops in COVID-19 vaccination rates have several causes, but taken together they signal that the effort to immunize Texans has entered a tough new phase – one that will rely more heavily than ever on physicians to distribute the vaccines, says David Lakey, MD, who is vice chancellor for health affairs and chief medical officer at The University of Texas System.


New Resource Helps Kids Manage COVID-19-Related Stresses - 05/05/2021

Texas physicians have unveiled a new tool to help parents support their children whose behavioral health is suffering due to the COVID-19 pandemic’s upheaval.The Texas Medical Association’s (TMA’s) School Reopening Workgroup, the Texas Pediatric Society (TPS), and members of TMA’s Committee on Behavioral Health produced “Your Child’s Feelings Matter,” a resource in English and Spanish to help parents recognize and support their children’s reactions to school disruptions and other changes the pandemic has forced upon their young lives.


Get Paid for COVID-19 Vaccination Costs Not Covered by Insurance Under New HHS Program; Webinar May 6 - 05/04/2021

Since physicians cannot bill patients for COVID-19 vaccine administration, a new federal program aims to fill in the gaps by covering the outstanding costs not covered by health insurance plans.


Trouble With COVID-19 Data Entry? The Texas Military Department Can Help - 05/04/2021

Many physicians offering COVID-19 vaccines face unfamiliar administrative chores, including reporting vaccinations to ImmTrac2, the state’s vaccine registry.


COVID-19: Telemedicine - 05/04/2021

View COVID-19 resources related to Telemedicine.


COVID-19: Payers / Insurance - 05/04/2021

Get COVID-19 resource related to payers / insurance.


COVID-19: Finances - 05/04/2021

View COVID-19 resources related to practice finances.


Fite Finds Points of Pride in COVID-Plagued Presidency - 05/01/2021

Outgoing TMA President Diana L. Fite, MD's COVID-Plagued Presidency


More COVID-19 Vaccines Available For Your Practice: Order Now - 04/30/2021

Texas’ COVID-19 vaccine supplies are well stocked, and physician practices are likely to see more allocations as the state shifts its vaccination efforts from large, mass vaccination sites “to those where Texans routinely receive medical care,” the Texas Department of State Health Services (DSHS) announced.


COVID-19 Public Health Emergency Extended; Telemedicine, Other Waivers Extended - 04/29/2021

The national public health emergency related to COVID-19 has been extended to July 20 and likely will be extended throughout 2021, the federal Health and Human Services (HHS) Department has announced.


Texas Resumes Johnson & Johnson Vaccine Administration - 04/26/2021

The latest COVID-19 vaccines information as of April 26, 2021


“Doctor, Will the Vaccines Give Me COVID-19?” - 04/23/2021

Are you getting frequently asked questions from patients about the COVID-19 vaccines? The Texas Medical Association has created a series of shareable social media graphics to help you answer those questions .


Saying Yes to Updated Vaccine Registry, No to Shaky COVID-19 Science - 04/23/2021

TMA on Wednesday asked state lawmakers to advance a bill to help modernize the state vaccine registry, and to oppose a bill that would require physicians to provide patients who get tested for COVID-19 a brochure that contains “information about preventative measures and treatments” for the disease.


COVID-19 Vaccines Info, April 16, 2021: Another 1.9 Million Doses Coming to Texas - 04/19/2021

The latest COVID-19 vaccines information as of April 16, 2021


Medicare 2% Payment Cut Suspended Through 2021 - 04/15/2021

President Joseph Biden this week extended the suspension of the Medicare sequestration, the federal government’s 2% across-the-board payment cut, through the end of the year.


Pause Administering Johnson & Johnson Vaccine, Health Officials Say - 04/15/2021

Physicians and health facilities should temporarily halt administering the Johnson & Johnson/Janssen COVID-19 vaccine following reports of blood clots in six people six to 13 days after receiving the vaccine.


Accelerating RPM: COVID-19 Speeds Adoption of Remote Patient Monitoring - 04/14/2021

Before March 2020, remote patient monitoring (RPM) was a tool endocrinologist Thomas Blevins, MD, used to help patients with diabetes track and regulate blood sugar levels and report the results back to him. But when the COVID-19 pandemic forced many doctors to turn to telemedicine, Dr. Blevins and the nine other physicians on staff at Austin Diabetes and Endocrinology had to rev up their RPM use.


Some Payers Resume Prior Authorization Requirements - 04/14/2021

Several commercial payers have resumed prior authorization time frames and requirements that had been suspended because of the COVID-19 emergency, while others will continue to approve prior auth requests or suspend them for at least part of the year.


COVID-19 Vaccines Info: Details on the Johnson & Johnson Vaccine - 04/14/2021

The latest COVID-19 vaccines information as of April 14, 2021


COVID-19: Practice Operations - 04/09/2021

View COVID-19 resources related to practice operations.


COVID-19: Compliance - 04/09/2021

Get COVID-19 resources related to compliance.


COVID-19 Vaccine Info, April 9, 2021: Another 1.9 Million Doses Coming to Texas - 04/09/2021

The latest COVID-19 vaccine information as of April 9, 2012


COVID-19 Vaccines: FDA Updates Dosage, Storage Information for Moderna Vaccine - 04/07/2021

The latest COVID-19 vaccine information as of April 7, 2021.


Diabetes, Asthma, Substance Use Disorders Now Considered High Risk for Severe COVID-19 - 04/07/2021

The Centers for Disease Control and Prevention has added several medical conditions to a list of those that place patients at high risk for a more severe case of COVID-19.


A Quarter of Texans Could Have COVID-19 Antibodies, Survey Finds - 04/06/2021

More than a quarter of Texans could have COVID-19 antibodies, according to preliminary data from a statewide seroprevalance study that seeks to understand the human antibody response to the virus that causes COVID-19